Medpace Holdings, Inc.
NASDAQ:MEDPMedical - Diagnostics & Research
-$4.51 today
- Market cap
- $18.09B
- Beta
- 1.18
- P/E (TTM)
- 28.2
- EPS (TTM)
- $16.19
Volume 0.21M
Average 0.36M
MEDP EPS (Basic)
Net income attributable to common shareholders divided by the weighted average basic shares outstanding.
Medpace Holdings, Inc.NASDAQ: MEDP
EPS (Basic) · Q3 FY2026 · quarter ended Sep 2026
EPS (Basic) grows in line with its trailing trend
Q3 FY2026 EPS (Basic) of $4.92 rose 24.6% year over year, behind the +25.2% change in trailing-twelve-month EPS (Basic). Sequentially, it rose 14.2% from the prior quarter. Over 3 fiscal years it compounded at +27.4% a year.
Context
- EPS (Basic) increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Basic) reaches the consensus estimate from 9 analysts of $18.24 (+16.6%) for the fiscal year ending Dec 2026, a slowdown from the +19.8% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $4.92+14.2% QoQ
- Last fiscal yearDec 2025
- $15.64+19.8% YoY
- LTMSep 2026
- $18.36+25.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +24.6% | +1.1% | -23.4 pp |
| 1 year | +19.8% | +16.6% | -3.1 pp |
| 3-year CAGR | +27.4% | +12.1% | -15.2 pp |
| 5-year CAGR | +11.8% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Basic) history
USD · from the income statement
- Latest · FY2025
- 15.64 USD
- Year-over-year change
- +19.8%
- 4-year CAGR
- +32.6%
| Period | Period end | EPS (Basic) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 15.64 | +19.8% |
| FY2024 | 2024-12-31 | 13.06 | +42.0% |
| FY2023 | 2023-12-31 | 9.20 | +21.5% |
| FY2022 | 2022-12-31 | 7.57 | +49.6% |
| FY2021 | 2021-12-31 | 5.06 | — |
EPS (Basic) vs competitors
How MEDP compares with its peers on the latest reported figures
- MEDP's LTM Sep 2026 EPS (Basic) of $18.36 is the highest of the 5 companies compared; the peer median is $1.68.
- Its year-over-year change of +25.2% is the 2nd highest of 5, against a peer median of -19.8%.
- Over three fiscal years its annual growth of +27.4% compares with a peer median of -5.7%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Sep 2026 | $18.36 | +25.2% | +27.4% | |
| LTM Jun 2026 | $8.13 | +16.5% | +10.8% | |
| LTM Jun 2026 | $4.29 | -56.1% | -22.2% | |
FTREFortrea Holdings Inc. | LTM Jun 2026 | -$0.93 | +91.9% | — |
| LTM Jun 2026 | -$4.84 | -266.7% | — | |
| Peer median (excluding MEDP) | $1.68 | -19.8% | -5.7% | |
Competitors are the stored peer set for MEDP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.14B | 1.46B | 1.89B | 2.11B | 2.53B |
| Cost of Revenue | 814.22M | 1.03B | 1.36B | 1.45B | 1.77B |
| Gross Profit | 328.16M | 432.44M | 524.51M | 656.31M | 760.62M |
| Gross Margin | 28.7% | 29.6% | 27.8% | 31.1% | 30.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 108.42M | 131.4M | 161.35M | 180.18M | 197.56M |
| Operating Expenses | 129.54M | 153.74M | 187.68M | 209.44M | 225.68M |
| Depreciation & Amortization | 21.12M | 22.34M | 26.33M | 29.25M | 28.12M |
| EBITDA | 223.08M | 308.11M | 362.5M | 505.17M | 570.5M |
| EBITDA Margin | 19.5% | 21.1% | 19.2% | 24.0% | 22.5% |
| Operating Income | 198.62M | 278.7M | 336.83M | 446.87M | 534.94M |
| Operating Margin | 17.4% | 19.1% | 17.9% | 21.2% | 21.1% |
| Interest Income | 0 | 0 | 0 | 25M | 0 |
| Interest Expense | 105K | 2.91M | 488K | 0 | 0 |
| Other Income / Expenses | 3.24M | 4.16M | (1.14M) | 29.05M | 7.44M |
| Income Before Tax | 201.85M | 282.86M | 335.68M | 475.92M | 542.38M |
| Pre-Tax Margin | 17.7% | 19.4% | 17.8% | 22.6% | 21.4% |
| Income Tax Expense | 20M | 37.49M | 52.87M | 71.54M | 91.25M |
| Net Income | 181.85M | 245.37M | 282.81M | 404.39M | 451.12M |
| Net Margin | 15.9% | 16.8% | 15.0% | 19.2% | 17.8% |
| EPS (Basic) | 5.06 | 7.57 | 9.20 | 13.06 | 15.64 |
| EPS (Diluted) | 4.81 | 7.28 | 8.88 | 12.63 | 15.28 |
| Weighted Avg Shares | 35.86M | 32.39M | 30.72M | 30.96M | 28.85M |
| Weighted Avg Shares (Diluted) | 37.7M | 33.67M | 31.84M | 32.01M | 29.53M |
Medpace Holdings, Inc.
NASDAQ:MEDP
Intrinsic Alpha fair value
Locked
Current Price
$646.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.